Table 2.
Selected characteristics of 1,197 individuals receiving treatment for pulmonary tuberculosis (PTB) at time of initiation of HAART by length of time between initiation of PTB treatmentand initiation of HAART.
| Characteristic at initiation of HAART |
Time between initiation ofPTB treatment and HAART | p-value | |||
|---|---|---|---|---|---|
| 0-30 days (n=334) |
31-60 days (n=289) |
61-120 days (n=320) |
> 120 days (n=254) |
||
| BMI < 18.5 | 108 (32.3) | 117 (40.5) | 103 (32.2) | 65 (25.6) | 0.0032 |
| Low hemoglobin | 259 (77.5) | 234 (81.0) | 232 (72.5) | 139 (54.7) | <0.0001 |
| CD4 count | |||||
| Median (IQR) | 43 (15-88) | 52 (21-104) | 82 (36-133) | 68 (27-138) | <0.0001† |
| Mean (95% CI) | 60 (53-67) | 69 (62-77) | 95 (86-105) | 92 (80-104) | <0.0001† |
| CD4<50 | 176 (52.7) | 134 (46.4) | 101 (31.6) | 90 (35.4) | <0.0001 |
| WHO stage IV | 63 (18.9) | 49 (17.0) | 60 (18.8) | 35 (13.8) | 0.3525 |
| Peripheral neuropathy | 20 (6.0) | 20 (6.9) | 30 (9.4) | 19 (7.5) | 0.4108 |
| History of PTB | 18 (5.4) | 18 (6.2) | 15 (4.7) | 9 (3,5) | 0.5281 |
Figures are n(% ) unless otherwise noted. P-values are 2-sided by chi-square testor
†
one-way ANOVA.